Nov 16, 2026
Alevoa is bringing greater transparency to telehealth through licensed provider evaluations, clear pricing, pharmacy disclosure, and accessible human support.
United States, November 16, 2026 -- As telehealth continues to change how people access healthcare, questions about provider qualifications, prescription fulfillment, and treatment costs remain important to patients considering online services. Alevoa, founded by Daniel Dauajare, is introducing a patient-focused model designed to make these details clearer from the beginning.

Operating across 50 states through licensed healthcare providers, Alevoa aims to address concerns surrounding unclear pricing, unidentified medical teams, and limited information about the pharmacies responsible for fulfilling prescriptions. Its approach places transparency and communication at the center of the patient experience.
The company's development was shaped by Dauajare's approximately ten years of experience in performance marketing across the legal, insurance, and home services industries. His background provided insight into how digital marketing influences consumer decisions. It also exposed him to practices in the telehealth market that he believed could leave prospective patients with unanswered questions about the services they were considering.
Rather than treating healthcare inquiries as routine sales leads, Dauajare established Alevoa around a different priority: helping people understand the process before making decisions about treatment.
Clinical Decisions Remain With Licensed Providers
Alevoa's service model begins with an online intake process, followed by an evaluation from a licensed healthcare provider. The provider reviews the submitted information and determines whether the requested treatment is appropriate for the individual.
This distinction is important in digital healthcare, where completing an online questionnaire should not be confused with receiving automatic medical approval. Alevoa states that treatment decisions remain with the licensed professionals responsible for evaluating each case.
If a provider determines that a requested treatment is not suitable, the individual is informed of that decision and receives an explanation. According to the company, patients are not charged for treatment that is not approved.
The model is intended to place professional judgment ahead of commercial expectations. It also reflects the company's position that patients should receive understandable information about their options rather than being encouraged to pursue treatment without an appropriate evaluation.
Alevoa does not guarantee medical results. Its approach emphasizes individual assessment and clear communication about what a treatment may or may not offer.
Clear Costs Before Treatment Begins
Unexpected charges can complicate the experience of accessing healthcare online. Alevoa seeks to reduce that uncertainty by presenting pricing before patients begin treatment.
The company says its pricing model is designed to make the financial commitment clear, without relying on undisclosed membership fees or charges introduced after a patient has entered the process.
This emphasis on upfront information is part of a broader effort to help patients make informed decisions. Understanding the cost of a service is an important consideration, particularly when comparing online healthcare options.
Alevoa's approach is intended to make the commercial side of the process easier to understand, allowing patients to consider the service and its costs before proceeding.
Making Pharmacy Information Easier to Identify
Prescription fulfillment is another area where Alevoa places emphasis on transparency. The company states that the pharmacy responsible for filling a prescription is identified on the prescription label, giving patients a way to identify the source of their medication.
Alevoa works with licensed pharmacy partners and describes its prescription compounded treatments as being prepared and fulfilled through U.S.-based operations.
Compounded medications require careful consideration. They are prepared for individual patients under particular circumstances and are not FDA-approved in the same way as commercially manufactured FDA-approved medications. Patients should discuss the suitability, potential risks, and available alternatives with a qualified healthcare professional.
By highlighting pharmacy identification, Alevoa aims to give patients more visibility into a part of the prescription process that can otherwise be difficult to understand when using online services.
Establishing Standards Before Expanding Advertising
Alevoa reports obtaining LegitScript certification before beginning its advertising efforts. LegitScript provides certification and monitoring services for healthcare-related businesses, assessing applicants against applicable standards.
For Dauajare, establishing this credential early was part of the company's effort to build its operations around accountability rather than making advertising the first priority.
The decision reflects a broader consideration in digital healthcare: marketing should communicate services responsibly, particularly when consumers are making decisions involving prescription treatments.
Alevoa's stated approach combines this emphasis on responsible communication with provider-led evaluations, identifiable pharmacy fulfillment, and pricing information presented before treatment begins.
Human Support Beyond the Online Intake Form
Alevoa also identifies customer service as a central part of its operating model. The company provides access to human support representatives to help address questions about the process, prescriptions, payments, and other service-related concerns.
Digital healthcare can make access more convenient, but convenience does not eliminate the need for communication. Patients may still require clarification or assistance after submitting their information. Alevoa aims to make that support available through direct interaction rather than relying exclusively on automated responses.
The company states that its support approach prioritizes timely assistance, with the goal of responding to inquiries within hours.
This focus reflects its view that a patient's experience should not end with an online submission. Clear answers and accessible support remain important throughout the process.
Building Relationships With Early Patients
As part of its launch, Alevoa introduced a founding-patient program for individuals who joined during its early development. Participating founding patients are offered locked-in founding rates, recognizing their early support as the company establishes its services.
Alevoa is also exploring opportunities to work with content creators and influencers to introduce more people to its approach to online healthcare. These potential collaborations are intended to expand awareness while communicating the company's focus on transparent pricing, licensed provider evaluations, and accessible customer support.
Through its website and social media channels, Alevoa continues to develop its presence and share information about its services.
Alevoa Recognized for Patient Focused Telehealth Services
Alevoa has been recognized by Best of Best Review as the “Best Patient Focused Telehealth Service in the United States of 2026.” The award recognizes the company's emphasis on licensed provider evaluations, transparent pricing, pharmacy disclosure, and accessible patient support.
Founded by Daniel Dauajare, Alevoa continues to prioritize clarity and communication throughout the online healthcare experience. This recognition reflects its commitment to making telehealth more transparent and patient focused.
A Patient Experience Built Around Greater Clarity
Alevoa brings together several priorities: licensed provider assessments, upfront pricing, identifiable pharmacy fulfillment, human customer support, and reported LegitScript certification.
For Dauajare, the company reflects an effort to apply a decade of digital marketing experience to healthcare, with a focus on making the patient journey clearer, from initial inquiry and provider evaluation to prescription fulfillment.
As online healthcare evolves, Alevoa positions transparency as central to the patient experience, ensuring people have clear information about who evaluates them, what services cost, and where prescriptions are fulfilled.
About Alevoa
Alevoa is a United States-based telehealth company founded by Daniel Dauajare, offering compounded prescription treatments through licensed providers and pharmacy partners in all 50 states. It emphasizes personalized evaluations, upfront pricing, pharmacy transparency, human support, and LegitScript certification.
For additional information, visit Alevoa. The company also shares updates and information through its Facebook, Instagram, Instagram Health, LinkedIn, TikTok, and YouTube accounts. For business inquiries, contact [email protected].
Contact Info:
Name: Daniel Dauajare
Email: Send Email
Organization: Alevoa
Website: https://www.alevoa.com/
Release ID: 89209654
Should you identify any discrepancies, concerns, or inaccuracies in the content provided in this press release or require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team is committed to addressing your concerns within 8 hours by taking necessary actions to resolve identified issues diligently or guiding you through the necessary steps for removal. Our dedication lies in providing accurate and reliable information.
MORE NEWS
RECOMMENDED
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.